• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Wednesday, April 1, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

JAX receives NIH grant to improve CRISPR-Cas9 accuracy

Bioengineer by Bioengineer
March 1, 2017
in Science News
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

A two-year grant totaling $455,000 from the National Institutes of Health to Michael V. Wiles, Ph.D., senior director of Technology Evaluation and Development at The Jackson Laboratory, will support research to improve the accuracy and efficiency of genome editing for research, drug testing and future therapeutic delivery.

The technology known as CRISPR-Cas9 has revolutionized scientists' ability to edit the genomes of plants and animals, including mice and humans, to study and manipulate the genome. However, the promise of consistent and reproducible therapeutic delivery of modifications to the genome faces technical obstacles, particularly when researchers attempt to insert relatively long segments of DNA into a genome.

Harnessing a precise natural process of DNA repair (known as homology directed repair or HDR) is vital for achieving a perfect, seamless replacement of a faulty gene within its native environment. CRISPR-Cas9 experiments in mice show that HDR doesn't always as efficiently as needed, and the current processes for screening mice for correctly edited DNA are time-consuming, laborious and expensive.

Wiles and his team are developing rigorous testing regimes to determine which processes and techniques lead to the highest accurate editing rates in the gene-editing process in mouse embryos.

"The broad goal of this work," Wiles says, "is to significantly improve the reliability and efficiency of targeted nuclease-mediated HDR by developing and validating a high-throughput, low-cost approach capable of testing multiple variables for targeting HDR directly in mouse zygotes, and making this information publicly available" to the research community.

###

The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, Maine, with a National Cancer Institute-designated Cancer Center, a facility in Sacramento, Calif., and a genomic medicine institute in Farmington, Conn. It employs 1,900 staff, and its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.

Media Contact

Sarah Laskowski
[email protected]
860-837-2102
@jacksonlab

http://www.jax.org

############

Story Source: Materials provided by Scienmag

Share12Tweet8Share2ShareShareShare2

Related Posts

Correcting Clock and Bmal1’s Role in Cancer Cells

April 1, 2026

Phages Modify Cytosine via Hydroxylation and Arabinofuranosylation

April 1, 2026

New Aurodox Compound from Streptomyces Shows Antibacterial Promise

April 1, 2026

Robotic Gripper Using Magnetic Tensegrity and Adaptive Energy Barrier for Enhanced UAV Perching

April 1, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1006 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    43 shares
    Share 17 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Correcting Clock and Bmal1’s Role in Cancer Cells

Phages Modify Cytosine via Hydroxylation and Arabinofuranosylation

New Aurodox Compound from Streptomyces Shows Antibacterial Promise

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.